Menu

About Us
GeM Registration
Company Insights

Department of Military Affairs Tender by Indian Army (GEM/2025/B/6161287)

D IFA RE 24 Cycloserine 250 mg Cap,D IFA RE 24 Fluticasone propionate lotion 0 DOT 05 bott of 10 ml

Darjeeling, West bengal
Goods
Qty:19.3K
EMD: ₹6
Department of Military Affairs Tender by Indian Army (GEM/2025/B/6161287)

Tender Timeline

Tender Issue
April 30, 2025 at 9:09 PM

Tender Title: Drugs and Pharmaceuticals

Reference Number: GEM/2025/B/6161287

Issuing Authority: Department of Military Affairs, Ministry of Defence

The Drugs and Pharmaceuticals tender (reference number GEM/2025/B/6161287) issued by the Department of Military Affairs under the Ministry of Defence aims to procure pharmaceutical products that include Cycloserine 250 mg Capsules and Fluticasone Propionate Lotion 0.05% (10 ml bottle), with a total quantity of 19,347 units.

Scope of Work and Objectives

The objectives of this tender are to ensure a steady supply of high-quality pharmaceutical products required for defense personnel and operations. The selected bidders will be responsible for the timely delivery of the specified drugs, adhering to the set technical and quality standards, and contributing to the operational efficiency of defense health services.

Eligibility Criteria

Participants must fulfill the following eligibility criteria:

  • Be a registered entity licensed to manufacture and supply pharmaceuticals.
  • Must possess relevant certifications indicating compliance with country-specific pharmaceutical regulations.
  • Proven experience in supplying drugs to government entities or large organizations is preferable.

Technical Requirements

Bidders must meet stringent technical requirements, including:

  • Compliance with national and international quality standards for pharmaceuticals.
  • Evidence of quality assurance processes in place during the manufacturing process.
  • Capability to provide the required dossier that includes product specifications, safety data sheets, and manufacturing licenses.

Financial Requirements

Participants are required to submit strong financial documentation, which includes:

  • Audited financial statements for the last fiscal year.
  • A declaration of turnover related to pharmaceutical supplies reflecting adequate capacity to fulfill the order.

Document Submission Details

Bidders must submit their proposals electronically via the designated procurement platform, ensuring that all required documentation is included. Submissions should be comprehensive, addressing each aspect of the tender requirements.

Special Provisions

The tender includes provisions that favor Micro, Small, and Medium Enterprises (MSEs), encouraging participation from startups in the pharmaceutical sector. Documentation proving MSE status must be provided.

Evaluation Process

The evaluation process will focus on the following criteria:

  • Technical Compliance: Adherence to technical and quality requirements.
  • Financial Viability: Stability and capability of the bidding entity as demonstrated in submitted financial documents.
  • Delivery Capability: Timelines and history of prior supply operations.

Delivery Locations

Goods must be delivered to designated locations specified by the Department of Military Affairs as per the procurement agreement to ensure logistical efficiency.

Contact Information

For further details regarding the tender process, prospective bidders may contact the Department of Military Affairs. Specific names or contact numbers will not be disclosed here; however, they can be found on the official government websites.

Tender BOQ Items

47 Items
1.

D IFA RE 24 Cycloserine 250 mg Cap

Cycloserine 250 mg Cap

Qty:300
Unit:no
30
2.

D IFA RE 24 Fluticasone propionate lotion 0 DOT 05 bott of 10 ml

Fluticasone propionate lotion 0.05% bott of 10 ml

Qty:10
Unit:bott
30
3.

D IFA RE 24 Fluticasone propionate inhaler for paed use 50mcg dose 120 metered doses

Fluticasone propionate inhaler for paed use 50mcg/dose, 120 metered doses

Qty:450
Unit:no
30
4.

D IFA RE 24 Fluticasone Propionate Inhaler for Adults 125 mcg dose

Fluticasone Propionate Inhaler for Adults 125 mcg/dose

Qty:500
Unit:no
30
5.

D IFA RE 24 Salmeterol 50 mcg plus Fluticasone 250 mcg multi dose dry powder inhaler of 60 doses

Salmeterol 50 mcg + Fluticasone 250 mcg multi dose dry powder inhaler of 60 doses

Qty:180
Unit:inhaler
30
6.

D IFA RE 24 Salmeterol Rotacap 50mcg

Salmeterol Rotacap 50mcg

Qty:100
Unit:no
30
7.

D IFA RE 24 Theophylline SR 400 mg Tab

Theophylline SR 400 mg Tab

Qty:100
Unit:no
30
8.

D IFA RE 24 Fexofenadine Hydrochloride Tab 120 mg

Fexofenadine Hydrochloride Tab 120 mg

Qty:5400
Unit:no
30
9.

D IFA RE 24 Glucosamine 250 mg plus Chondroitin Sulphate 200 mg Cap

Glucosamine 250 mg + Chondroitin Sulphate 200 mg Cap

Qty:1200
Unit:no
30
10.

D IFA RE 24 Immunoglobulin Intravenous 2 DOT 5 gm Inj

Immunoglobulin Intravenous 2.5 gm Inj

Qty:3
Unit:ampvial
30
11.

D IFA RE 24 Ibuprofen Gel tube of 20 gm

Ibuprofen Gel, tube of 20 gm

Qty:600
Unit:tube
30
12.

D IFA RE 24 Leflunomide 20 mg Tab

Leflunomide 20 mg Tab

Qty:300
Unit:no
30
13.

D IFA RE 24 Naproxen gel tube of 20 gm

Naproxen gel, tube of 20 gm

Qty:600
Unit:tube
30
14.

D IFA RE 24 Nimesulide gel tube of 20 gm

Nimesulide gel, tube of 20 gm

Qty:530
Unit:tube
30
15.

D IFA RE 24 Amoxycillin oral susp containing Amoxycillin base 125 mg per 5 ml after reconstitution bottle of 30 ml

Amoxycillin oral susp containing Amoxycillin base 125 mg per 5 ml after reconstitution (bottle of 30 ml)

Qty:600
Unit:bott
30
16.

D IFA RE 24 Amikacin Sulphate 250 mg 2 ml Inj

Amikacin Sulphate 250 mg/2 ml Inj

Qty:470
Unit:ampvial
30
17.

D IFA RE 24 Norfloxacin 400 mg Tab

Norfloxacin 400 mg Tab

Qty:1200
Unit:no
30
18.

D IFA RE 24 Ofloxacin 200 mg Tab

Ofloxacin 200 mg Tab

Qty:100
Unit:no
30
19.

D IFA RE 24 Sulphamethoxazole 200 mg and Trimethoprim 40 mg per 5 ml bottle of 50 60 ml suspension

Sulphamethoxazole 200 mg and Trimethoprim 40 mg per 5 ml, bottle of 50-60 ml suspension

Qty:10
Unit:bott
30
20.

D IFA RE 24 Sulphamethoxazole 400 mg and Trimethoprim 80 mg Tab

Sulphamethoxazole 400 mg & Trimethoprim 80 mg Tab

Qty:600
Unit:no
30
21.

D IFA RE 24 Acyclovir 250 mg Inj

Acyclovir 250 mg Inj

Qty:50
Unit:ampvial
30
22.

D IFA RE 24 Acyclovir Syp 400 mg 5 ml

Acyclovir Syp 400 mg/5 ml

Qty:5
Unit:bott
30
23.

D IFA RE 24 Linezolid 2 mg ml 300 ml Inj

Linezolid 2 mg/ml, 300 ml Inj

Qty:5
Unit:bott
30
24.

D IFA RE 24 Oseltamivir 75 mg Cap

Oseltamivir 75 mg Cap

Qty:50
Unit:no
30
25.

D IFA RE 24 Brimonidine 0 DOT 2 and Brinzolamide 1 Eye Drop Bott of 5ml

Brimonidine 0.2% & Brinzolamide 1% Eye Drop, Bott of 5ml

Qty:50
Unit:bott
30
26.

D IFA RE 24 Nepafenac mocronised suspension 0 DOT 1 BAK free in 5 ml bottle

Nepafenac mocronised suspension 0.1% (BAK free), in 5 ml bottle

Qty:5
Unit:bott
30
27.

D IFA RE 24 Nitroglycerine Glyceryltrinitrate 5mg Inj

Nitroglycerine/ Glyceryltrinitrate 5mg Inj

Qty:20
Unit:amp
30
28.

D IFA RE 24 Iron Syp Pediatric Each 5 ml Containing elemental iron of 50 mg as iron polymaltose complex in 200 ml bottle

Iron Syp Pediatric Each 5 ml Containing elemental iron of 50 mg as iron polymaltose complex in 200 ml bottle

Qty:50
Unit:bott
30
29.

D IFA RE 24 Methotrexate 15mg Tab

Methotrexate 15mg Tab

Qty:300
Unit:no
30
30.

D IFA RE 24 Paroxetine 25mg Tab

Paroxetine 25mg Tab

Qty:1500
Unit:no
30
31.

D IFA RE 24 Baclofen XL 30 mg Tab

Baclofen XL 30 mg Tab

Qty:650
Unit:no
30
32.

D IFA RE 24 Clozapine 50 mg Tab

Clozapine 50 mg Tab

Qty:500
Unit:no
30
33.

D IFA RE 24 Thiamine 100mg ml Inj 2ml Amp

Thiamine 100mg/ml Inj, 2ml Amp

Qty:140
Unit:amp
30
34.

D IFA RE 24 MDI spacer with mask and fish mouth valve for pediatrics set

MDI spacer with mask and fish mouth valve for pediatrics, set

Qty:70
Unit:set
30
35.

D IFA RE 24 Fluticasone Propionate and Formoterol 120 MDI

Fluticasone Propionate & Formoterol, 120 MDI

Qty:320
Unit:no
30
36.

D IFA RE 24 Cabergoline 0 DOT 25mg Tab

Cabergoline 0.25mg Tab

Qty:120
Unit:no
30
37.

D IFA RE 24 Misoprostol 600mcg Tab

Misoprostol 600mcg Tab

Qty:730
Unit:no
30
38.

D IFA RE 24 Diclofenac 75mg ml Inj 1ml Amp for IV bolus

Diclofenac 75mg/ml Inj, 1ml Amp for IV bolus

Qty:600
Unit:amp
30
39.

D IFA RE 24 Silicone Ring Vaginal Pessary

Silicone Ring Vaginal Pessary

Qty:6
Unit:no
30
40.

D IFA RE 24 Cell Culture Rabies Vaccine vial of 1 ml

Cell Culture Rabies Vaccine vial of 1 ml

Qty:900
Unit:dose
30
41.

D IFA RE 24 Test Mantoux Sufficent for 10 tests

Test Mantoux (Sufficent for 10 tests)

Qty:1
Unit:set
30
42.

D IFA RE 24 Airway long transparent Oropharyngeal set consisting of size Length 000 3 DOT 5 00 5 DOT 0 0 5 DOT 0 1 7 DOT 0 2 9 DOT 0 3 10 DOT 0 4 1 DOT 0

Airway long transparent Oropharyngeal set consisting of size Length 0003.5, 00 5.0, 05.0 17.0, 29.0, 310.0,41.0

Qty:5
Unit:no
30
43.

D IFA RE 24 Adhesive Incise drape 50 x 45 cm

Adhesive Incise drape 50 x 45 cm

Qty:10
Unit:no
30
44.

D IFA RE 24 Apparatus Anaesthetic facemask with air cushion transparent size 0 infant

Apparatus Anaesthetic facemask with air cushion, transparent, size 0, infant

Qty:2
Unit:no
30
45.

D IFA RE 24 Apparatus Anaesthetic facemask with air cushion transparent size 1 paediatric

Apparatus Anaesthetic facemask with air cushion transparent size 1 paediatric

Qty:2
Unit:no
30
46.

D IFA RE 24 Apparatus Anaesthetic facemask Antistatic with air cushion transparent size 3 adult with valve

Apparatus Anaesthetic facemask (Antistatic) with, air cushion (transparent) size 3, adult with valve

Qty:1
Unit:no
30
47.

D IFA RE 24 Apparatus Anaesthetic facemask Antistatic with air cushion transparent size 4

Apparatus Anaesthetic facemask (Antistatic) with air cushion (transparent), size 4

Qty:2
Unit:no
30

General Information

Item Category
D IFA RE 24 Cycloserine 250 mg Cap , D IFA RE 24 Fluticasone propionate lotion 0 DOT 05 bott of 10 ml , D IFA RE 24 Fluticasone propionate inhaler for paed use 50mcg dose 120 metered doses , D IFA RE 24 Fluticasone Propionate Inhaler for Adults 125 mcg dose , D IFA RE 24 Salmeterol 50 mcg plus Fluticasone 250 mcg multi dose dry powder inhaler of 60 doses , D IFA RE 24 Salmeterol Rotacap 50mcg , D IFA RE 24 Theophylline SR 400 mg Tab , D IFA RE 24 Fexofenadine Hydrochloride Tab 120 mg , D IFA RE 24 Glucosamine 250 mg plus Chondroitin Sulphate 200 mg Cap , D IFA RE 24 Immunoglobulin Intravenous 2 DOT 5 gm Inj , D IFA RE 24 Ibuprofen Gel tube of 20 gm , D IFA RE 24 Leflunomide 20 mg Tab , D IFA RE 24 Naproxen gel tube of 20 gm , D IFA RE 24 Nimesulide gel tube of 20 gm , D IFA RE 24 Amoxycillin oral susp containing Amoxycillin base 125 mg per 5 ml after reconstitution bottle of 30 ml , D IFA RE 24 Amikacin Sulphate 250 mg 2 ml Inj , D IFA RE 24 Norfloxacin 400 mg Tab , D IFA RE 24 Ofloxacin 200 mg Tab , D IFA RE 24 Sulphamethoxazole 200 mg and Trimethoprim 40 mg per 5 ml bottle of 50 60 ml suspension , D IFA RE 24 Sulphamethoxazole 400 mg and Trimethoprim 80 mg Tab , D IFA RE 24 Acyclovir 250 mg Inj , D IFA RE 24 Acyclovir Syp 400 mg 5 ml , D IFA RE 24 Linezolid 2 mg ml 300 ml Inj , D IFA RE 24 Oseltamivir 75 mg Cap , D IFA RE 24 Brimonidine 0 DOT 2 and Brinzolamide 1 Eye Drop Bott of 5ml , D IFA RE 24 Nepafenac mocronised suspension 0 DOT 1 BAK free in 5 ml bottle , D IFA RE 24 Nitroglycerine Glyceryltrinitrate 5mg Inj , D IFA RE 24 Iron Syp Pediatric Each 5 ml Containing elemental iron of 50 mg as iron polymaltose complex in 200 ml bottle , D IFA RE 24 Methotrexate 15mg Tab , D IFA RE 24 Paroxetine 25mg Tab , D IFA RE 24 Baclofen XL 30 mg Tab , D IFA RE 24 Clozapine 50 mg Tab , D IFA RE 24 Thiamine 100mg ml Inj 2ml Amp , D IFA RE 24 MDI spacer with mask and fish mouth valve for pediatrics set , D IFA RE 24 Fluticasone Propionate and Formoterol 120 MDI , D IFA RE 24 Cabergoline 0 DOT 25mg Tab , D IFA RE 24 Misoprostol 600mcg Tab , D IFA RE 24 Diclofenac 75mg ml Inj 1ml Amp for IV bolus , D IFA RE 24 Silicone Ring Vaginal Pessary , D IFA RE 24 Cell Culture Rabies Vaccine vial of 1 ml , D IFA RE 24 Test Mantoux Sufficent for 10 tests , D IFA RE 24 Airway long transparent Oropharyngeal set consisting of size Length 000 3 DOT 5 00 5 DOT 0 0 5 DOT 0 1 7 DOT 0 2 9 DOT 0 3 10 DOT 0 4 1 DOT 0 , D IFA RE 24 Adhesive Incise drape 50 x 45 cm , D IFA RE 24 Apparatus Anaesthetic facemask with air cushion transparent size 0 infant , D IFA RE 24 Apparatus Anaesthetic facemask with air cushion transparent size 1 paediatric , D IFA RE 24 Apparatus Anaesthetic facemask Antistatic with air cushion transparent size 3 adult with valve , D IFA RE 24 Apparatus Anaesthetic facemask Antistatic with air cushion transparent size 4
Ministry Name
Ministry of Defence
Department Name
Department of Military Affairs
Organisation Name
Indian Army
State
West bengal
City
Darjeeling

Financial Information

EMD Amount
₹6.00
Bid Offer Validity
180 (Days)
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
Inspection Required
No

Tender Documents

6 Documents
GeM-Bidding-7763208.pdfMain Document
Other DocumentsOTHER COMPLIANCE
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
Buyer uploaded ATC documentATC ATC
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Similar Tenders

View All

D IFA22 Caffeine Citrate 20 mgml Inj 1ml vial,D IFA22 Salmeterol 25 mcg plus Fluticasone 125 mg MDI

GEM
Goods
Qty:26.4K
6 Files
Indian Army
DARJEELING, WEST BENGAL
Boq › Boql
D IFA22 Caffeine Citrate 20 mgml Inj 1ml vial , D IFA22 Salmeterol 25 mcg plus Fluticasone 125 mg MDI 120 doses , D IFA22 Caffeine Citrate 20mgml Oral Solution 1ml Syp , D IFA22 Fluconazole 10 mgml 30 ml Syp , D IFA22 Linezolid dry powder 100mg30ml , D IFA22 Frusemide 10 mgml 30 ml Syp , D IFA22 Domperidone Syp 1 mgml bott of 30 ml , D IFA22 Dicyclomine drops of 15 ml , D IFA22 Norflox Syp 100mg5ml bott of 30 ml , D IFA22 Phenobarbitone Syp 20 mg5 ml bott of 60 ml , D IFA22 Prednisolone Syp 5mg5ml in bott of 30 ml , D IFA22 Roxithromycin 50mg5ml Syp in bott of 30 ml , D IFA22 Natural Surfactant 25 to 80mgml Inj , D IFA22 Triclofos Syp 500 mg5ml in 30ml bottle , D IFA22 Human Milk fortifier 2 gm sachet , D IFA22 Calcium Phosphate 80 mg5 ml Syp 200ml bott , D IFA22 Bupropion HCl 150 mg SR Tab , D IFA22 Buspirone HCl 10 mg Tab , D IFA22 Clonazepam 0dot5 mg Tab , D IFA22 Clomipramine HCl 25 mg Tab , D IFA22 Doxepin HCl 75 mg Cap , D IFA22 Fluoxetine HCl 20 mg Cap , D IFA22 Haloperidol decanoate 50 mgml Inj in 1ml amp , D IFA22 Imipramine 25 mg Tab , D IFA22 Lithium Carbonate 300 mg CapTab , D IFA22 Memantine 5 mg Tab , D IFA22 Aripiprazole 10 mg Tab , D IFA22 Zolpidem 10 mg Tab , D IFA22 Quetiapine 50 mg Tab , D IFA22 Paroxetine XR 12dot5 Tab , D IFA22 Amisulpride 200mg Tab , D IFA22 Theophylline anhydrous syrup 60 mg in 5 ml as 100ml bottledot , D IFA22 Beclomethasone Dipropionate 50 mcg and Levosalbutamol 50 mcg per metred dose in CFC free MDI , D IFA22 Salmeterol 50 mcg plus Fluticasone 500 mcg Accuhaler , D IFA22 Cough Syrup Each 5 ml contains Chlorpheniramine Maleate IP 3 mg Ammonium Chloride IP 110 mg Sodium Citrate IP 46 mg Menthol IP 0dot9 mg Bott of 110 ml , D IFA22 Cough expectorant syp 5 ml containingDiphenhydramine HCl 14dot08mg AmmoniumChloride 0dot138 gm Sodium Citrate 57dot03mg Menthol 1dot14 mg in flavoured syp basebott of 100 110 ml , D IFA22 Codeine Phosphate 10 mg plus Chlorpheniramine Maleate 4 mg per 5 ml Syp bottle of 100 ml , D IFA22 Disodium Hydrogen Citrate Syp Bott of 100ml , D IFA22 Antimicrobial Hand Gel Containing Ethyl Alcohol 60prcntge plus Cyclomethicone C1215 Alkyl Lactate plus Cetyl Lactate plus Phenoxyethanol plus Stearyl Alcohol with moisturizer , D IFA22 Anti phlebitis cream Tube of 15 g20 g , D IFA22 Haemostatic sponge gelatin 80 mm long 50mm broad 10 mm thick , D IFA22 Desmopressin Nasal spray 0dot1 mgml in vial of 2dot5 ml , D IFA22 Vit B1 50 mg Inj , D IFA22 Vitamin A solution IP 50 ml , D IFA22 Calcium 9 mg plus Calcium gluconate 50 mg Inj for IV use 10 ml Injection , D IFA22 Iron Syp Paediatric each 5 ml containing elemental Iron 2550 mg and Folic Acid 500 mcg bottle of 200 ml , D IFA22 Multi Vit Inj IV 210 ml with minimum constituents having Thiamine B130mgml Pyridoxine B6 30mgml and B12 Cyanocobalamin300 mcgml , D IFA22 Niacin 500mg Tab , D IFA22 Drop VitaminD3 Cholecalciferol 200 IUml , D IFA22 Dapagliflozin 5 mg plus Metformin 1000 mg IR Tab
April 30, 2025
May 22, 2025 at 10:00 AM
View Details

D IFA RE 21 Human Insulin Analogue Long acting basal Inj 100 IU ml Recombinant DNA origin 300 IU Di

₹158.00
GEM
Goods
Qty:11.6K
6 Files
Indian Army
DARJEELING, WEST BENGAL
Boq › Boql
D IFA RE 21 Human Insulin Analogue Long acting basal Inj 100 IU ml Recombinant DNA origin 300 IU Disposable Pen with 5 needles per pen , D IFA RE 21 Gliclazide MR 30 mg Tab , D IFA RE 21 Glipizide 5mg Tab , D IFA RE 21 Sitagliptin 50 mg Metformin 1000 mg Tab , D IFA RE 21 Insulin Lispro Biphasic injection I DOT P 25 Insulin Lispro and 75 Insulin Lispro protamine suspension , D IFA RE 21 Sirolimus 1mg Tab , D IFA RE 21 Pioglitazone Hydrochloride 15mg Tab , D IFA RE 21 Alendronate Sodium 70mg Tab , D IFA RE 21 Neostigmine 0 DOT 5mg 1ml Inj , D IFA RE 21 Cisatracurium 2 mg ml Inj 10ml vial , D IFA RE 21 Tacrolimus 1mg Prolonged Release Cap , D IFA RE 21 Mycophenolate Mofetil 750mg Tab , D IFA RE 21 Intravenous Immunoglobulin IvIg 10gm Bott of 50ml , D IFA RE 21 Calcium Phosphate 0 DOT 24 mg 5 ml Syp , D IFA RE 21 Calcium Acetate 500 mg Tab , D IFA RE 21 Carnitine 200 mg Tab , D IFA RE 21 Acyclovir Ophth Ointment 3 w w in 5 gm tube , D IFA RE 21 Ciprofloxacin HCl 0 DOT 3 Tube of 5 gm , D IFA RE 21 Ciprofloxacin HCl 0 DOT 3 Dexamethasone DOT 1 bott of 5ml , D IFA RE 21 Cyclosporine eye drop 0 DOT 05 bott of 3 ml , D IFA RE 21 Fluorescein Sodium 20 3 ml Inj , D IFA RE 21 Flurbiprofen Sodium ophthalmic soln 0 DOT 03 vial of 5 ml , D IFA RE 21 Homatropine Hydrochloride Soln 2 , D IFA RE 21 Ketorolac Tromethamine 0 DOT 4 Eye drops , D IFA RE 21 Natamycin 3 eye drops in 3 ml bott , D IFA RE 21 Carboxy Methyl Cellulose CMC 1 Gel , D IFA RE 21 Ofloxacin 0 DOT 3 bott of 5 ml , D IFA RE 21 Pilocarpine Nitrate eye solution 2 bott of 5 ml , D IFA RE 21 Pilocarpine Intracameral Inj 0 DOT 5 Pilocarpine nitrate intra ocular Inj without preservatives amp of 01ml each , D IFA RE 21 Prednisolone acetate 1 w v bott of 5 ml , D IFA RE 21 Sodium Chloride 6 w w ointment Tube of 3 gm , D IFA RE 21 Azelaic acid 20 cream tube of 15 gm , D IFA RE 21 Cream Luliconazole tube of 15 gm , D IFA RE 21 Tobramycin 0 DOT 3 bott of 5 ml , D IFA RE 21 Tropicamide 1 with 5 Phenylephrine eye drops bott of 5 ml , D IFA RE 21 Tropicamide Eye solution 1 bott of 5 ml , D IFA RE 21 Trypan Blue 0 DOT 6 Inj in vial of 1ml , D IFA RE 21 Amphotericin B 0 DOT 5 eye drops bott of 5 ml , D IFA RE 21 Atropine Sulphate 1 w v Eye Drop Bott of 3 ml , D IFA RE 21 Atropine Sulphate Oint 1 Tube of 3gm , D IFA RE 21 Olopatadine Hydrochloride 0 DOT 1 Ophthalmic Soln Bott of 5ml , D IFA RE 21 Olopatadine 0 DOT 2 Ophthalmic Soln bott of 5 ml , D IFA RE 21 Proparacaine Eye Drops 0 DOT 5 Bott of 5 ml , D IFA RE 21 Moxifloxacin HCl 0 DOT 5 and Dexamethasone 0 DOT 1 Ophthalmic Soln Bott of 5ml , D IFA RE 21 Diphenhydramine 10 15 mg per 5 ml and Ammonium Chloride 100 150 mg Sodium Citrate 50 85 mg per 5ml Syp Bott of 100ml , D IFA RE 21 Beclomethasone Dipropionate nasal spray 50 mcg per dose metered dose 150 units , D IFA RE 21 Betahistine Dihydrochloride 16mg Tab , D IFA RE 21 Clotrimazole 1 w v IP Lignocaine 2 w v IP ear drop bott of 10ml , D IFA RE 21 Chloramphenicol 5 w v Clotrimazole 1 w v Betamethasone 0 DOT 25 w v Lignocaine HCl 2 w v in bott of 5 ml , D IFA RE 21 Xylometazoline HCl 0 DOT 05 w v nasal solution for paed use bott of 10ml
April 30, 2025
May 22, 2025 at 10:00 AM
View Details

EPIRUBICIN HCL 10 MG INJ,Isosfamide Inj 1g vial with 3 amp of 2 ml each Mesna,METHOTREXATE 15MG PRE

₹294.00
GEM
Goods
Qty:22.7K
4 Files
Indian Army
PUNE, MAHARASHTRA
Boq › Boql
EPIRUBICIN HCL 10 MG INJ , Isosfamide Inj 1g vial with 3 amp of 2 ml each Mesna , METHOTREXATE 15MG PRESERVATIVE FREE 3 ML INJ , SUNITINIB 50 MG CAP , Sunitinib 25 mg Tab , EXEMESTANE 25 MG TAB , Pegylated GCSF 6 mg Inj , LEUPROLIDE 3 75 MG INJ , CABAZITAXEL 60 MG INJ , CABOZATINIB 40 MG TAB , TAB TRIFLURIDINE 8 19 MG TIPIRACIL 20 MG , FLUNARIZINE 5 MG TAB , PRAMIPEXOLE 0 25 MG TAB
April 30, 2025
May 21, 2025 at 2:00 PM
View Details

Tab Paracetamol 650 mg,Syp Brufen,Inj PCM infusion 1 gm 100 ml bott,Tab Naproxen 250mg,Tab Etoricox

₹1,028.00
GEM
Goods
Qty:4.4L
5 Files
Indian Air Force
KACHCHH, GUJARAT
Boq › Boql
Tab Paracetamol 650 mg , Syp Brufen , Inj PCM infusion 1 gm 100 ml bott , Tab Naproxen 250mg , Tab Etoricoxib 120 mg , Tab Ketorolac DT , Tab Febuxostat 40mg , Syp Fexofenadine , Tab Montelukast LC , Tab Gabapentin 300mg , Tab sod volproate CR 200 mg , Formeterol 6 mcg and Budesonide 200mcg MDI , Tab Cipzox , T Metformin 500mg and Sita 50mg , T Methylcobalamine 1500mcg , Tab Autrin , Mouth ulcer gel , Tab Ticagleror 90 mg , T Propranolol 40 mg , T Ramipril 2 point 5 mg , Tab Telmisartan 40 mg , T Indapamide SR 1 point 5 mg , T Prazocine XL 5mg , T Ramipril 5 mg , T Ramipril 10 mg , T Telma 40mg and HCTZ 12 point 5 mg , Clotrimazole powder 75 gm , Soframycine cream , Oint Mupirocin , Povidone iodine gargle soln , Hydrogen peroxide soln 400ml , T Meftal spas , Syp Digene , Sporolac sachet , No pile cream , T Thyroxine 50mcg , T Metformin SR 500mg , T Metformin SR 1gm , T Doxylamine succin , T Dydrogesteron 10mg , T Voglibose 0 pint 2 mg , T Sitagliptin 100 mg , Inj Insulin Aspart Novarapid , T Vildagliptin 50 mg , T Met 1000mg and Sita 50mg , T Empagliflozin 10 mg , T Empagliflozin 25 mg , T Vilda 50mg and Met 500 mg , T Thyroxine 25mcg , T Thyroxine 100 mcg , T Thyroxine 12 point 5 mg , Syp Calcium , Tab Calcium 500 mg , Inj Insulin Glargin 100 iu 3 ml , Eye drop ciproflox , Eye drop carboxymethyl cellulose , Eye drop Olopatadin , NS Nasal drop , MDI Seroflo , Aerocort rotocaps bott , Levolin MDI , Levolin respules , Syp Bromhexine , Syp Cough Bromi combi , Syp TBH , Dextrose monohydrate for oral use 100gm pkt , Inj Sod bicarbonate 7 point 5 perc 10 ml , Syp Citralka , Cap Tamsulosin point 4 mg , Inj Nuerobion forte 3ml , Tab Multi vitamin , Vit D3 sachet , T Montelukast 10 mg , Diclogel , T Glucosamine 500 mg , T Etoricoxib 90 mg , T Augmentin 625 mg , T Augmentin 1 gm , Syp Augmentin 228 mg , Inj Augmentin 1 point 2 gm , T Thyroxin 75 mcg , T Dapagliflozin 10 mg , Trop T Kit , T Voglibose 0 pint 3 mg , Sterile surgical gloves 7 point 5 , Knee cap , Roller Bandage 5 cm , Roller Bandage 10 cm , Elastic adhesive plaster 10x4 mt , Sulus suture 3 0 , Prolene suture 3 0 , Paper roll for semi auto haematology analyser , Strip Glucose and albumin bott of 100 , Rabipur vaccine , Syp DPH , Corn cap pkt of 4 , T Tripsin chymotripsin , ED Waxol , Syb combiflam , Thermal paper for semi auto analyser , Stromatolyser bott of 500 ml , Cell clean , Cell pack solution 20 ltr , Enalapril 10 mg Tam , T Etoricoxib 120 mg , Xylomet nasal drop , Tab Naproxen 500mg
April 30, 2025
May 21, 2025 at 12:00 PM
View Details

Frequently Asked Questions

The eligibility requirements include being a registered entity, capable of supplying pharmaceuticals and possessing relevant certifications. Companies must also demonstrate prior experience in fulfilling government contracts in the pharmaceutical sector. Additionally, submission of a valid manufacturing license is mandatory. Qualified bidders are expected to show adherence to all regulatory obligations related to the manufacture and supply of pharmaceutical products.

Bidders must comply with specified technical specifications for both Cycloserine 250 mg Capsules and Fluticasone Propionate Lotion 0.05%. This includes adhering to national and international quality standards like WHO guidelines. Documentation must include proof of compliance with pharmacopoeial standards and safety data related to the drugs supplied. In addition, suppliers must provide detailed descriptions of manufacturing processes and quality control measures.

The EMD requirements involve submitting a specified amount along with the tender proposal. This deposit serves as a financial assurance against the bid and is typically refunded upon successful completion of the tender process. Bidders should refer to the official documents for the exact amount necessary and ensure compliance with EMD payment procedures to avoid disqualification.

Submissions must be made electronically through the designated procurement platforms. All documents should be uploaded in accepted formats, including PDFs and standard image file types. It is essential to ensure that all submissions are completed by the stipulated deadlines to ensure eligibility for evaluation.

Micro, Small, and Medium Enterprises (MSEs) will benefit from provisions designed to encourage their participation in the tendering process, including reduced financial requirements for EMD and preferential consideration during evaluation. Additionally, these enterprises may also receive assistance in terms of capacity building and support in meeting quality standards, enabling a more inclusive bidding environment aligned with government policies.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders